Orchid Pharma Limited (BOM:524372)

Orchid Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	36.01	225.97	43.07	156.94	898.92
Short-Term Investments	-	0.15	40.15	0.06	8	0.12
Trading Asset Securities	-	-	-	-	150.21	-
Cash & Short-Term Investments	2,439	36.16	266.12	43.13	315.15	899.04
Cash Growth	384.25%	-86.41%	517.08%	-86.32%	-64.95%	-72.38%
Accounts Receivable	-	1,955	2,152	1,706	1,357	679.69
Other Receivables	-	48.07	1.58	0.01	0.71	0.09
Receivables	-	2,004	2,154	1,706	1,358	679.78
Inventory	-	2,642	2,287	1,727	1,529	1,417
Prepaid Expenses	-	22.18	37.91	71.18	25.66	125.74
Other Current Assets	-	3,203	265.17	429.94	2,271	2,572
Total Current Assets	-	7,908	5,010	3,976	5,499	5,693
Property, Plant & Equipment	-	6,360	6,192	5,931	6,775	8,588
Long-Term Investments	-	458.4	444.41	454.98	4.18	3.38
Other Intangible Assets	-	149.19	3.86	3.37	3.69	247.73
Other Long-Term Assets	-	663.79	601.97	739.28	91.01	66.95
Total Assets	-	15,539	12,252	11,106	12,373	14,599
Accounts Payable	-	2,296	1,744	1,677	1,100	1,016
Accrued Expenses	-	131.62	124.31	40.03	43.23	94.61
Short-Term Debt	-	140.48	1,410	228.41	28.43	-
Current Portion of Long-Term Debt	-	-	415.58	369.47	224	624.22
Current Portion of Leases	-	3.33	-	-	-	-
Other Current Liabilities	-	28.55	25.85	93.04	25.64	14.67
Total Current Liabilities	-	2,600	3,719	2,408	1,421	1,749
Long-Term Debt	-	1,204	1,488	2,082	4,275	5,040
Long-Term Leases	-	3.7	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	32.26	32.26	32.26	32.26
Other Long-Term Liabilities	-	24.4	24.89	23.27	27.26	41.29
Total Liabilities	-	3,844	5,366	4,632	5,843	6,939
Common Stock	-	507.19	408.16	408.16	408.16	408.16
Additional Paid-In Capital	-	8,465	4,645	4,645	4,645	4,645
Retained Earnings	-	-16,180	-17,097	-17,558	-17,553	-13,557
Comprehensive Income & Other	-	18,902	18,931	18,979	19,029	16,164
Total Common Equity	12,242	11,695	6,886	6,474	6,529	7,660
Shareholders' Equity	12,242	11,695	6,886	6,474	6,529	7,660
Total Liabilities & Equity	-	15,539	12,252	11,106	12,373	14,599
Total Debt	1,649	1,352	3,313	2,680	4,527	5,664
Net Cash (Debt)	789.49	-1,316	-3,047	-2,636	-4,212	-4,765
Net Cash Per Share	15.57	-27.20	-74.66	-64.59	-103.20	-11691.27
Filing Date Shares Outstanding	50.67	50.72	40.82	40.82	40.82	40.82
Total Common Shares Outstanding	50.67	50.72	40.82	40.82	40.82	40.82
Working Capital	-	5,308	1,291	1,569	4,078	3,944
Book Value Per Share	241.38	230.58	168.72	158.61	159.96	187.67
Tangible Book Value	12,056	11,545	6,883	6,470	6,525	7,412
Tangible Book Value Per Share	237.71	227.64	168.62	158.53	159.87	181.60
Land	-	256.47	218.47	122.87	122.87	258.95
Buildings	-	1,849	1,783	1,439	1,439	1,678
Machinery	-	10,773	10,097	10,095	10,092	10,312
Construction In Progress	-	163.94	464.63	97.84	74.31	150.72

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.